Expanding HMOs potential: BASF and Glycosyn sign strategic partnership for improved gut health

The partnership facilitates the commercialization of human milk oligosaccharides (HMOs) for broad use in dietary supplements, functional nutrition and medical food

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

14 Jan 2021 --- Chr. Hansen is on track to fulfill its 2025 strategy following its Q1 2020/21 results, which revealed overall organic sales growth of 10 percent. However, there are... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

23 Dec 2020 --- The year saw COVID-19 tint every facet of nutrition, as the pandemic’s march caused industry disruptions and heightened interest in immunity. From... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

11 Dec 2020 --- This week in nutrition news, IFF and DuPont’s Nutrition and Biosciences division received approval from the EU for a merger intended to close in 2021.... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

03 Dec 2020 --- As every lactating parent produces unique breast milk that evolves across their child’s babyhood, personalization and regional considerations are a key... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

05 Nov 2020 --- Kyowa Hakko Bio is establishing a new facility in Thailand to manufacture human milk oligosaccharides (HMOs). The move seeks to further expand the company’s... Read More

trans